**_老虎社区_美港股上老虎

茅台科创投资基金入股星赛生物

天眼查App显示，近日，青岛星赛生物科技有限公司发生工商变更，股东新增茅台科创（北京）投资基金合伙企业（有限合伙），同时公司注册资本从约672.3万人民币增至约687.6万人民币。青岛星赛生物科技有限公司成立于2014年1月，法定代表人为马波，经营范围含检验检测服务、生物化工产品技术研发、细胞技术研发和应用、工业酶制剂研发、发酵过程优化技术研发等。公开信息显示，星赛生物专注于单细胞维度医疗器械与科学仪器的研发与产业化。

茅台科创投资基金入股星赛生物

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":293824571584752,"tweetId":"293824571584752","gmtCreate":1712740004991,"gmtModify":1712740006471,"author":{"id":3469825833798402,"authorId":3469825833798402,"authorIdStr":"3469825833798402","name":"咕咕_3166","avatar":"https://static.tigerbbs.com/a25f9dd9f0e446d3efad0c87609406f2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>**</p></body></html>","htmlText":"<html><head></head><body><p>**</p></body></html>","text":"**","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/293824571584752","repostId":2426745501,"repostType":2,"repost":{"id":"2426745501","pubTimestamp":1712736960,"share":"https://www.laohu8.com/m/news/2426745501?lang=&edition=full","pubTime":"2024-04-10 16:16","market":"sh","language":"zh","title":"茅台科创投资基金入股星赛生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2426745501","media":"澎湃新闻","summary":"天眼查App显示，近日，青岛星赛生物科技有限公司发生工商变更，股东新增茅台科创（北京）投资基金合伙企业（有限合伙），同时公司注册资本从约672.3万人民币增至约687.6万人民币。青岛星赛生物科技有限公司成立于2014年1月，法定代表人为马波，经营范围含检验检测服务、生物化工产品技术研发、细胞技术研发和应用、工业酶制剂研发、发酵过程优化技术研发等。公开信息显示，星赛生物专注于单细胞维度医疗器械与科学仪器的研发与产业化。","content":"<div>\n<p>天眼查App显示，近日，青岛星赛生物科技有限公司发生工商变更，股东新增茅台科创（北京）投资基金合伙企业（有限合伙），同时公司注册资本从约672.3万人民币增至约687.6万人民币。青岛星赛生物科技有限公司成立于2014年1月，法定代表人为马波，经营范围含检验检测服务、生物化工产品技术研发、细胞技术研发和应用、工业酶制剂研发、发酵过程优化技术研发等。公开信息显示，星赛生物专注于单细胞维度医疗器械与...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410161739875f697e&s=b\">Web Link</a>\n\n</div>\n","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>茅台科创投资基金入股星赛生物</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n茅台科创投资基金入股星赛生物\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-10 16:16 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410161739875f697e&s=b><strong>澎湃新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>天眼查App显示，近日，青岛星赛生物科技有限公司发生工商变更，股东新增茅台科创（北京）投资基金合伙企业（有限合伙），同时公司注册资本从约672.3万人民币增至约687.6万人民币。青岛星赛生物科技有限公司成立于2014年1月，法定代表人为马波，经营范围含检验检测服务、生物化工产品技术研发、细胞技术研发和应用、工业酶制剂研发、发酵过程优化技术研发等。公开信息显示，星赛生物专注于单细胞维度医疗器械与...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410161739875f697e&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"600519":"贵州茅台","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","LU0577902454.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (USD) ACC","BK0183":"MSCI概念","LU0072913022.USD":"UBS (LUX) EQUITY FUND -  GREATER CHINA \"P\" (USD) ACC","BK0012":"证金概念","LU0211977185.USD":"EASTSPRING INVESTMENTS GREATER CHINA EQUITY \"A\" ACC","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","LU0405327148.USD":"ALLSPRING CHINA A FOCUS \"A\" (USD) ACC","BK0196":"行业龙头","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC","LU0405327494.USD":"ALLSPRING CHINA A FOCUS \"I\" (USD) ACC","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","LU0067412154.USD":"UBS (LUX) EQUITY FUND -  CHINA OPPORTUNITY \"P\" (USD) ACC","LU1105468828.SGD":"Allianz Total Return Asian Equity AM DIS H2-SGD","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","LU0084288322.USD":"Natixis Asia Equity RD USD","LU0348814723.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"A\" (USD) INC  NC","LU0370786039.SGD":"Fidelity Greater China A-SGD","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","LU0594300419.USD":"富达中国消费基金A","LU0456846285.SGD":"JPMorgan Funds - Greater China A (acc) SGD","LU0051755006.USD":"摩根大通中国A (dist)","LU0516423174.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (USD) ACC","LU0326950275.SGD":"Schroder ISF China Opportunities A Acc SGD-H","BK0015":"沪股通50","LU0181495838.USD":"施罗德新兴亚洲A Acc","BK0028":"国家队","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU0873338254.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (USD) INC","LU0052750758.USD":"富兰克林中国基金A Acc","LU0651946864.USD":"贝莱德新兴市场股票收益A2","LU0918141887.USD":"安联亚洲实际收益股票基金","LU0577902371.SGD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (SGD) ACC","LU1051768304.USD":"贝莱德新兴市场股票收益A6","LU0359201612.USD":"贝莱德中国基金A2","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU0516422366.SGD":"Fullerton Lux Funds - Asia Focus Equities A Acc SGD","LU1146622755.USD":"安本中国A股股票基金A Acc","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","LU0251143458.SGD":"Fidelity Emerging Markets A-SGD","BK0188":"融资融券","LU0516422952.EUR":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (EUR) ACC","BK0187":"一线龙头","LU0140636845.USD":"施罗德大中华区股票A Acc","LU0048580855.USD":"富达大中华区A","LU0880133367.SGD":"UBS (LUX) EQUITY FUND CHINA OPPORTUNITY USD \"P\" (SGD) ACC","LU0501845795.SGD":"瑞银大中华区股票基金P Acc SGD","BK0215":"饮品"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410161739875f697e&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2426745501","content_text":"天眼查App显示，近日，青岛星赛生物科技有限公司发生工商变更，股东新增茅台科创（北京）投资基金合伙企业（有限合伙），同时公司注册资本从约672.3万人民币增至约687.6万人民币。青岛星赛生物科技有限公司成立于2014年1月，法定代表人为马波，经营范围含检验检测服务、生物化工产品技术研发、细胞技术研发和应用、工业酶制剂研发、发酵过程优化技术研发等。公开信息显示，星赛生物专注于单细胞维度医疗器械与科学仪器的研发与产业化。","news_type":1},"isVote":1,"tweetType":1,"viewCount":37,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}